Cosmetics Maker Estee Lauder Boosts FY22 Forecast, Q2 Earnings Beat Expectations

Estée Lauder Companies Inc EL reported Q2 FY22 sales of $5.54 billion, an increase of 14%, beating the consensus of $5.50 billion.

  • Net sales grew in every region and product category, reflecting early stages of recovery in brick-and-mortar retail stores, primarily in western markets, and strength in online. Organic net sales increased 11%.
  • The owner of Clinique has increased its digital presence and rolled out features such as virtual try-on to sidestep disruptions caused by a resurgence in COVID-19 cases.
  • After the easing of pandemic restrictions, sales of its MAC lipsticks and Jo Malone London perfumes have also risen in Europe and North America.
  • Adjusted EPS of $3.01 increased 15% on a reported basis and in constant currency, beating the consensus of $2.64.
  • Guidance: Estee Lauder raised its FY22 revenue and profit forecasts, betting on strong demand for its Clinique skincare and Tom Ford fragrance products in Western markets.
  • The Company expects annual net sales to rise between 13% and 16%, compared with its previous forecast of a 12% to 15% increase.
  • It estimates an adjusted EPS of $7.43 - $7.58 per share, compared to its prior outlook of $7.23 and $7.38.
  • For Q3 FY22, the Company expects sales growth of 10% - 12% Y/Y, with adjusted EPS of $1.55 - $1.65.
  • Price Action: EL shares are up 0.26% at $320.00 during the premarket session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!